Bruyère O - Search Results

1

Evaluation of the impact of 6-month training by whole body vibration on the risk of falls among nursing home residents, observed over a 12-month period: a single blind, randomized controlled trial.

Buckinx F, Beaudart C, Maquet D, Demonceau M, Crielaard JM, Reginster JY, Bruyère O. Buckinx F, et al. Among authors: bruyere o. Aging Clin Exp Res. 2014 Aug;26(4):369-76. doi: 10.1007/s40520-014-0197-z. Epub 2014 Jan 28. Aging Clin Exp Res. 2014. PMID: 24469903 Clinical Trial.

2

Evidence of nutriceutical effectiveness in the treatment of osteoarthritis.

Reginster JY, Gillot V, Bruyere O, Henrotin Y. Reginster JY, et al. Among authors: bruyere o. Curr Rheumatol Rep. 2000 Dec;2(6):472-7. doi: 10.1007/s11926-000-0023-9. Curr Rheumatol Rep. 2000. PMID: 11123100 Review.

3

Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. Reginster JY, et al. Among authors: bruyere o. Lancet. 2001 Jan 27;357(9252):251-6. doi: 10.1016/S0140-6736(00)03610-2. Lancet. 2001. PMID: 11214126 Clinical Trial.

4

Biochemical markers in glucocorticoid-induced osteoporosis.

Bruyere O, Stephaniak N, Reginster JY. Bruyere O, et al. Front Horm Res. 2002;30:49-59. doi: 10.1159/000061072. Front Horm Res. 2002. PMID: 11892270 Review. No abstract available.

5

Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate.

Bruyere O, Honore A, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY. Bruyere O, et al. Osteoarthritis Cartilage. 2003 Jan;11(1):1-5. doi: 10.1053/joca.2002.0848. Osteoarthritis Cartilage. 2003. PMID: 12505481 Free article. Clinical Trial.

6

Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritis.

Bruyere O, Dardenne C, Lejeune E, Zegels B, Pahaut A, Richy F, Seidel L, Ethgen O, Henrotin Y, Reginster JY. Bruyere O, et al. Bone. 2003 May;32(5):541-5. doi: 10.1016/s8756-3282(03)00059-0. Bone. 2003. PMID: 12753870

7

Validation and comparative evaluation of the osteoporosis self-assessment tool (OST) in a Caucasian population from Belgium.

Richy F, Gourlay M, Ross PD, Sen SS, Radican L, De Ceulaer F, Ben Sedrine W, Ethgen O, Bruyere O, Reginster JY. Richy F, et al. Among authors: bruyere o. QJM. 2004 Jan;97(1):39-46. doi: 10.1093/qjmed/hch002. QJM. 2004. PMID: 14702510 Free article.

8

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.

Reginster JY, Sarkar S, Zegels B, Henrotin Y, Bruyere O, Agnusdei D, Collette J. Reginster JY, et al. Among authors: bruyere o. Bone. 2004 Feb;34(2):344-51. doi: 10.1016/j.bone.2003.10.004. Bone. 2004. PMID: 14962813 Clinical Trial.

9

Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.

Christgau S, Henrotin Y, Tankó LB, Rovati LC, Collette J, Bruyere O, Deroisy R, Reginster JY. Christgau S, et al. Among authors: bruyere o. Clin Exp Rheumatol. 2004 Jan-Feb;22(1):36-42. Clin Exp Rheumatol. 2004. PMID: 15005002 Clinical Trial.

10

Social support and health-related quality of life in hip and knee osteoarthritis.

Ethgen O, Vanparijs P, Delhalle S, Rosant S, Bruyère O, Reginster JY. Ethgen O, et al. Among authors: bruyere o. Qual Life Res. 2004 Mar;13(2):321-30. doi: 10.1023/B:QURE.0000018492.40262.d1. Qual Life Res. 2004. PMID: 15085904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

503 results

Search Page